Prinova on scaling complex sports nutrition formulas

A decade of innovation in sports nutrition formulation has run into a problem: the factory floor.

Long associated with specialized, high-volume products designed exclusively for elite athletes and competitive bodybuilders, the category has become more accessible to a wide-ranging consumer base.

As the products have reached a broader audience, the global sports nutrition market climbed to a valuation of $59.13bn in 2025, expanding at a compound annual growth rate (CAGR) of 7.81%.¹ This growth means that whether a product is targeted at an elite marathoner or a casual lifestyle consumer, the criteria for success have changed. Consumers across all segments now expect clean-label, plant-based, and multi-functional profiles to coexist with premium taste, instant solubility, and on-the-go convenience.

However, satisfying these lifestyle needs forces a pivot away from traditional manufacturing models. Meeting these expectations requires brands to diversify their portfolios by introducing versatile delivery systems, such as single-serve stick packs and advanced capsules, alongside their foundational bulk powder lines. The commercial challenge lies in maintaining the massive manufacturing efficiencies of legacy lines while simultaneously scaling highly complex, low-tolerance new formulations.

As a global contract manufacturer and ingredient distributor, Prinova has observed firsthand how these evolving demands directly impact the production floor. Bridging the gap between a promising bench-scale concept and a stable, high-speed commercial run introduces a distinct set of physical and logistical hurdles, creating a significant scale-up bottleneck.

The scale-up challenge

The primary obstacle is particle physics. Modern performance products routinely combine structurally mismatched raw materials, such as dense minerals, amino acids, botanical extracts, and plant-based proteins, within a single formula. During high-speed industrial blending and mechanical filling, these materials can behave unpredictably.

Severe differences in particle size, density, and mass cause natural separation on the line, leading to ingredient settling or heavy clumping. On an automated, high-output production line, this physical variance results in uneven dosing, clogged equipment, and compromised product consistency that threatens strict label claims.

These technical hurdles are often compounded by the way the industry typically operates, which is by treating ingredient procurement and final manufacturing as separate steps. While sourcing actives from multiple independent brokers and shipping them to a third-party blender remains the standard for most brands – and can still work for a basic whey isolate – the tight tolerances of modern, multi-ingredient formulations are exposing the operational risks of this approach.

When sourcing and production are disconnected, a minor variance in raw material mesh size or a slight supply disruption at a single vendor can unexpectedly halt an entire high-speed commercial run.

Over the past decade, Prinova has significantly expanded its manufacturing footprint both globally and in the US, including facilities in Tennessee and Utah.

This has enabled it to increase capacity, strengthen supply-chain resilience, and support increasingly sophisticated sports nutrition manufacturing that enables functionality across multiple applications, from stick packs to capsules and powders.

Eliminating the bottleneck

Addressing these physical variances requires moving upstream of the blending line. Prinova’s particle engineering capabilities address this at the source: for fine powders prone to caking and poor flow, precision fluid bed agglomeration builds particles up into larger, uniform granules that move freely through automated equipment and disperse readily in liquid.

Where density mismatch drives segregation during transit or mechanical filling, precision micronization brings materials to a consistent mesh size, removing the variance at its source. Together, these interventions are what keep fill weights and label claims consistent run after run.

For formulas incorporating volatile or sensitive bioactives, encapsulation shields ingredients from heat, moisture, and incompatible compounds. As a byproduct, this reduces the off-notes that functional botanicals and high-dose amino acids typically introduce.

Getting the particle engineering right at this stage gives a formula a genuine chance of behaving at commercial scale the way it did in the lab, with flow and stability confirmed at pilot scale before the formula ever reaches a commercial line. However, particle engineering alone doesn’t fully solve the scaling equation.

Tackling a fragmented supply chain

For innovative sports nutrition products, a fragmented supply chain is as much of a barrier to market as the particle engineering challenges on the production floor. Managing multiple independent vendors for ingredient procurement, custom particle processing, and final contract manufacturing introduces numerous handoffs, compounding operational risk and escalating costs.

Working with a vertically integrated partner, one where ingredient sourcing, particle processing, and contract manufacturing sit under the same roof and the same quality control framework, changes how formulation risk is managed. When the team sourcing raw materials is the same team managing agglomeration, particle processing, and high-speed packaging, critical material data informs every stage of production instead of being lost as it moves between separate vendors.

A vertically integrated model, such as Prinova’s, allows formulation issues to be identified earlier in development, reducing the need for corrective action during commercial manufacturing. By integrating ingredient sourcing, particle processing and manufacturing within the same quality framework, manufacturers can identify potential issues, including moisture sensitivity, particle variability, and poor solubility, during ingredient selection rather than after production has begun.

For brands operating in a market where speed to shelf is as important as formula integrity, consolidating these functions under one partner also reduces the timeline between concept and commercial launch in ways that a fragmented model structurally cannot.

Adapting to the new standard of sports nutrition

The structural shift underway in sports nutrition, from a category built around a handful of high-volume staples to one demanding dozens of complex, multi-ingredient formats, is still accelerating. For brands looking to scale innovative formulations reliably and at speed, the manufacturing partnerships they build now will define their competitive position in the years to come.

As the sports nutrition segment expands into broader lifestyle markets, Prinova continues its commitment to invest into the future and meet the ever-evolving needs of both consumers and manufacturers.

Successfully bridging the gap between innovative formulation and commercial-scale execution depends as much on manufacturing partnerships as formulation itself. The difference between the right partner and the wrong one often shows up as a bottleneck on the production floor long before the root cause is identified on the balance sheet.

References